v3.25.2
NOTE 8 – OPERATING LEASES (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2023
Lessee, Lease, Description [Line Items]      
Prepaid Expense, Current $ 350 $ 2,540  
Operating Lease, Payments 1,100    
[custom:OperatingLeaseOtherPayments] $ 50    
Lessee, Operating Lease, Description On June 10, 2023, the Company entered into a plant facility lease agreement with a related party commencing June 9, 2023 which expires on June 30, 2028. Under this agreement, the monthly rental payments are $18,000 throughout the term of the lease excepting the month of June 2023 the rent is $7,920. The plant has been approved by the FDA   for the production of our OTC drug Xcellderma.  Under this agreement, the Company is also leasing the equipment in the plant facility through five (5) annual rent payments of $10,000, which are due on the 15th day of each June from June 2023 to June 2027.    
Office Lease [Member]      
Lessee, Lease, Description [Line Items]      
Operating Lease, Cost $ 17,050 18,150  
Office Lease [Member] | Monthly Rental Payments [Member]      
Lessee, Lease, Description [Line Items]      
Operating Leases, Future Minimum Payments Due 1,650    
Office Lease [Member] | Security Deposit [Member]      
Lessee, Lease, Description [Line Items]      
Prepaid Expense, Current 800    
Plant Facility [Member]      
Lessee, Lease, Description [Line Items]      
Capital Lease Obligations, Current     $ 7,920
Plant Facility [Member] | Monthly Rental Payments [Member]      
Lessee, Lease, Description [Line Items]      
Operating Leases, Future Minimum Payments Due 18,000    
Plant Lease [Member]      
Lessee, Lease, Description [Line Items]      
Operating Lease, Cost 192,771 161,462  
Equipment Lease [Member]      
Lessee, Lease, Description [Line Items]      
Operating Lease, Cost $ 10,336 $ 7,377